Urinary arsenic levels and risk of renal injury in a cross-sectional study in open population

Revista de Investigacion Clinica

Volumn 64, Issue 6, 2012, Pages 609-614

  Robles Osorio, María Ludivina ^a   Ṕerez Maldonado, Iván N ^b   Del Campo, Daniel Martiń ^b   Montero Perea, Diana ^a   Avileś Romo, Itzel ^a   Sabath Silva, Elizabeth ^c   Sabath, Ernesto ^d  

^a UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^d Hospital General de Queretaro   (Mexico)

Author keywords

1 microglobulin; Albuminuria; Arsenic; Chronic kidney disease

Indexed keywords

ALPHA 1 MICROGLOBULIN; ARSENIC; BIOLOGICAL MARKER;

ADULT; ALBUMINURIA; ARSENIC URINE LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; HUMAN; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; AGED; ALBUMINURIA; ALPHA-GLOBULINS; ARSENIC; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK; SOCIOECONOMIC FACTORS; SUBURBAN POPULATION; URBAN POPULATION; WATER POLLUTANTS, CHEMICAL;

EID: 84875857864     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ATSDR 2011. Toxicological Profile for Arsenic. Update. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
2. Ongley LK, Sherman L, Armienta A, Concilio A, Ferguson-Salinas C. Arsenic in the soils of Zimapan, México. Environmental Pollution 2007; 145: 793-9.
3. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J 2003; 79: 391-6. (Pubitemid 36993968)
4. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008; 300: 814-22.
5. Navas-Acien A, Sharrett AR, Silbergeld FK, Schwartz BS, Nachman KE, Burke TA, et al. Arsenic exposure and cardiovascular disease: A systematic review of the epidemiologic evidence. Am J Epidemiol 2005; 162: 1037-49. (Pubitemid 41746616)
6. Wang CH, Jeng JS, Yip PK, Chen CL, Hsu LI, Hsueh YM, et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 2002; 105: 1805-09.
7. Rosado JL, Ronquillo D, Kordas K, Rojas O, Alatorre J, Lopez P, et al. Arsenic Exposure and Cognitive Performance in Mexican Schoolchildren. Environ Health Perspect 2007; 115: 1371-5.
8. Jauge P, Del Razo LM. Uric acid levels in plasma and urine in rats chronically exposed to inorganic As (III) and As (V). Toxicol Lett 1985; 25: 31-5. (Pubitemid 15233260)
9. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: A standardized mortality ratio analysis. Environ Health 2007; 6: 4-10.
10. Hsueh YM, Chung CJ, Shiue HS, Chen JB, Chiang SS, Yang MH, et al. Urinary arsenic species and CKD in a Taiwanese population: A case-control study. Am J Kidney Dis 2009; 59: 859-70.
11. Nordberg GF, Jin T, Hong F, Zhang A, Buchet JP, Bernard A. Biomarkers of cadmium and arsenic interactions. Toxicol Appl Pharmacol 2005; 206: 191-7. (Pubitemid 40828238)
12. Thomas LD, Hodgson S, Nieuwenhuijsen M, Jarup L. Early kidney damage in a population exposed to cadmium and other heavy metals. Environ Health Perspect 2009; 117: 181-4.
13. Parikh CR, Lu JC, Coca SG, Devarajan P. Tubular proteinuria in acute kidney injury: A critical evaluation of current status and future promise. Ann Clin Biochem 2010; 47: 301-12.
14. Nanayakkara S, Senevirathna ST, Karunaratne U, Chandrajith R, Harada KH, Hitomi T, et al. Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study. Environ Health Prev Med 2011. In press.
15. Stefanovic V, Djukanovic L, Cukuranovic R, Bukvic D, Lezaic V, Maric I, et al. Beta 2-microglobulin and alpha1-microglobulin as markers of Balkan endemic nephropathy, a worldwide disease. Ren Fail 2011; 33: 176-83.
16. Liu J, Liu Y, Habeebu SM, Waalkes MP, Klaasen CD. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metalothionein-I/II null mice. Toxicology 2000; 147: 157-66. (Pubitemid 30618874)
17. Thomas D. Unraveling arsenic-glutathione connections. Toxicol Sciences 2009; 107: 309-11.
18. Carbrey JM, Song L, Zhou Y, Yoshinaga M, Rojek A. Reduced arsenic clearance and increased toxicity in aquaglyceroporin-9-null mice. Proc Natl Acad Sci USA 2009; 106: 15956-60.
19. Sabath E, Robles-Osorio ML. Medio ambiente y riñón: nefrotoxicidad por metales pesados. Nefrología 2012. En prensa.
20. Trejo-Acevedo A, Díaz-Barriga F, Carrizales L, Domínguez G, Costilla R, Ize-Lema I, Yarto-Ramírez M, et al. Exposure assessment of persistent organic pollutans and metals in Mexican children. Chemosphere 2009; 74: 974-80.